Device Trial Radar · NCT01648920
A Study to Explore the Utility of Fractional Exhaled Nitric Oxide (FeNO) Compared With Methacholine Challenge (MCC) Testing in the Assessment of Patients With Suspected But Undiagnosed Asthma
Last checked: Nov 19, 2026Latest source record: Apr 9, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Jun 2012
Primary completion
Nov 2012
Study completion Nov 2012
Sponsor
- Lead sponsor
- Aerocrine ABNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 25, 2012
Design
- Study type
- Observational
- Who can join
- All sexes, from 7 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Objective: To explore the utility of Fractional Exhaled Nitric Oxide (FeNO) compared with Methacholine Challenge (MCC) testing in assessing patients with suspected but undiagnosed asthma Number of participants: Approximately 50 subjects will be enrolled Reference product: NIOX MINO® Instrument (09-1100) Performance assessments: FeNO measurements will be performed according to the "Perform FeNO Measurement" guidelines on page 7 of the NIOX MINO® User Manual. MCC testing will be performed according to the ATS guidelines and the allergy and asthma specialists procedure for conducting MCC tests Safety assessments: The Investigator is responsible for the detection, reporting, and documentation of events meeting the definition of an Adverse Event (AE) and/or Serious Injuries as provided in this clinical investigation plan from the time that informed consent has been provided and during the study period Criteria for evaluations: This is an exploratory study and there are currently no plans for a formal statistical analysis. Information gained from this study may used to design and power subsequent studies in patients with suspected but undiagnosed asthma. Information collected will be summarized in a clinical study report
Conditions
- Asthma
Interventions
NIOX MINO® Instrument (09-1100)Device
The NIOX MINO® Instrument (09-1100) is a 10 second test based on exhaled breath measured at a 50 ml/second flow rate.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Methacholine Challenge (MCC) ResultsTime frame: approximately 1-hour
- Mean FeNO Levels by Methacholine Challenge (MCC) Results: MCC ResultsTime frame: approximately 1-hour
- FeNO by Methacholine Challenge (MCC) Results: FeNO <25ppbTime frame: approximately 1-hour
18 more outcomes with a free account
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Allergy and Asthma Specialists, PC
Blue Bell, Pennsylvania
Allergy and Asthma Specialists, PC
Collegeville, Pennsylvania
Allergy and Asthma Specialists, PC
Doylestown, Pennsylvania
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.